论文信息 - A mechanistic model predicting hematopoiesis and tumor growth to optimize docetaxel + epirubicin (ET) administration in metastatic breast cancer (MBC): Phase I trial - 字舞流文

A mechanistic model predicting hematopoiesis and tumor growth to optimize docetaxel + epirubicin (ET) administration in metastatic breast cancer (MBC): Phase I trial

Athanassios Iliadis | Jérôme Guitton | Dominique Barbolosi | Catherine Rioufol | Brigitte Tranchand | Benoit You | Christophe Meille | G. Freyer